Aliases & Classifications for Vaginitis

Aliases & Descriptions for Vaginitis:

Name: Vaginitis 12 41 42 14 69
Infective Vaginitis 69

Classifications:



External Ids:

Disease Ontology 12 DOID:2170
ICD9CM 35 616.1 616.10
MeSH 42 D014627
NCIt 47 C26911

Summaries for Vaginitis

MedlinePlus : 41 what is vaginitis? vaginitis, also called vulvovaginitis, is an inflammation or infection of the vagina. it can also affect the vulva, which is the external part of a woman's genitals. vaginitis can cause itching, pain, discharge, and odor. vaginitis is common, especially in women in their reproductive years. it usually happens when there is a change in the balance of bacteria or yeast that are normally found in your vagina. there are different types of vaginitis, and they have different causes, symptoms, and treatments. what are the different causes of vaginitis? bacterial vaginosis (bv) is the most common vaginal infection in women ages 15-44. it happens when there is an imbalance between the "good" and "harmful" bacteria that are normally found in a woman's vagina. many things can change the balance of bacteria, including taking antibiotics douching using an intrauterine device (iud) having unprotected sex with a new partner having many sexual partners yeast infections (candidiasis) happen when too much candida grows in the vagina. candida is the scientific name for yeast. it is a fungus that lives almost everywhere, including in your body. you may have too much growing in the vagina because of antibiotics pregnancy diabetes, especially if it is not well-controlled corticosteroid medicines trichomoniasis can also cause vaginitis. trichomoniasis is a common sexually transmitted disease. it is caused by a parasite. you can also have vaginitis if you are allergic or sensitive to certain products that you use. examples include vaginal sprays, douches, spermicides, soaps, detergents, or fabric softeners. they can cause burning, itching, and discharge. hormonal changes can also cause vaginal irritation. examples are when you are pregnant or breastfeeding, or when you have gone through menopause. sometimes you can have more than one cause of vaginitis at the same time. what are the symptoms of vaginitis? the symptoms of vaginitis depend on which type you have. with bv, you may not have symptoms. you could have a thin white or gray vaginal discharge. there may be an odor, such as a strong fish-like odor, especially after sex. yeast infections produce a thick, white discharge from the vagina that can look like cottage cheese. the discharge can be watery and often has no smell. yeast infections usually cause the vagina and vulva to become itchy and red. you may not have symptoms when you have trichomoniasis. if you do have them, they include itching, burning, and soreness of the vagina and vulva. you may have burning during urination. you could also have gray-green discharge, which may smell bad. how is the cause of vaginitis diagnosed? to find out the cause of your symptoms, your health care provider may ask you about your health history do a pelvic exam look for vaginal discharge, noting its color, qualities, and any odor study a sample of your vaginal fluid under a microscope in some cases, you may need more tests. what are the treatments for vaginitis? the treatment depends on which type of vaginitis you have. bv is treatable with antibiotics. you may get pills to swallow, or cream or gel that you put in your vagina. during treatment, you should use a condom during sex or not have sex at all. yeast infections are usually treated with a cream or with medicine that you put inside your vagina. you can buy over-the-counter treatments for yeast infections, but you need to be sure that you do have a yeast infection and not another type of vaginitis. see your health care provider if this is the first time you have had symptoms. even if you have had yeast infections before, it is a good idea to call your health care provider before using an over-the-counter treatment. the treatment for trichomoniasis is usually a single-dose antibiotic. both you and your partner(s) should be treated, to prevent spreading the infection to others and to keep from getting it again. if your vaginitis is due to an allergy or sensitivity to a product, you need to figure out which product is causing the problem. it could be a product that you started using recently. once you figure it out, you should stop using the product. if the cause of your vaginitis is a hormonal change, your health care provider may give you estrogen cream to help with your symptoms. can vaginitis cause other health problems? it is important to treat bv and trichomoniasis, because having either of them can increase your risk for getting hiv or another sexually transmitted disease. if you are pregnant, bv or trichomoniasis can increase your risk for preterm labor and preterm birth. how can i prevent vaginitis? to help prevent vaginitis do not douche or use vaginal sprays use a condom when having sex avoid clothes that hold in heat and moisture wear cotton underwear

MalaCards based summary : Vaginitis, also known as infective vaginitis, is related to vaginal cancer and vaginal discharge, and has symptoms including leukorrhea, vaginal pruritus and vaginal odor. An important gene associated with Vaginitis is ESR1 (Estrogen Receptor 1). The drugs Desogestrel and Estradiol have been mentioned in the context of this disorder. Affiliated tissues include testes, uterus and colon.

Wikipedia : 71 Vaginitis, also known as vaginal infection and vulvovaginitis, is an inflammation of the vagina and... more...

Related Diseases for Vaginitis

Diseases related to Vaginitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 395)
id Related Disease Score Top Affiliating Genes
1 vaginal cancer 12.3
2 vaginal discharge 12.2
3 postmenopausal atrophic vaginitis 12.2
4 vaginal disease 12.2
5 vaginal atresia 12.1
6 vaginal adenosarcoma 12.0
7 vaginal yolk sac tumor 11.9
8 vaginal squamous papilloma 11.9
9 vaginal spindle cell epithelioma 11.8
10 vaginal carcinosarcoma 11.8
11 transverse vaginal septum 11.8
12 longitudinal vaginal septum 11.8
13 vaginal adenoma 11.7
14 vaginal tubulovillous adenoma 11.7
15 vaginal mullerian papilloma 11.7
16 vulvovaginitis 11.7
17 vaginal villous adenoma 11.7
18 vaginal germ cell malignant tumor 11.7
19 vaginal tubular adenoma 11.7
20 vaginal squamous tumor 11.7
21 vaginal benign neoplasm 11.7
22 vaginal glandular tumor 11.7
23 enterocele 11.6
24 uterus bicornis bicollis with partial vaginal septum and unilateral hematocolpos with ipsilateral renal agenesis 11.6
25 isolated partial vaginal agenesis 11.6
26 vaginal endometrial stromal sarcoma 11.6
27 vaginal endometrial stromal tumor 11.6
28 benign vaginal carcinosarcoma 11.6
29 bacterial vaginosis 11.3
30 trichomoniasis 11.3
31 mayer-rokitansky-kuster-hauser syndrome 11.2
32 pelvic inflammatory disease 11.1
33 leukorrhea 11.1
34 ectopic pregnancy 11.1
35 vulvovaginal candidiasis 11.1
36 chorioamnionitis 11.0
37 cervical intraepithelial neoplasia 11.0
38 vulvitis 11.0
39 genital herpes 11.0
40 placenta praevia 11.0
41 premature ovarian failure 11.0
42 endometrial cancer 11.0
43 q fever 10.9
44 malignant skin fibrous histiocytoma 10.8
45 sjogren's syndrome 10.8
46 fallopian tube carcinoma 10.8
47 human immunodeficiency virus infectious disease 10.8
48 childhood vagina botryoid rhabdomyosarcoma 10.7
49 leukoplakia of vagina 10.7
50 vagina sarcoma 10.7

Graphical network of the top 20 diseases related to Vaginitis:



Diseases related to Vaginitis

Symptoms & Phenotypes for Vaginitis

UMLS symptoms related to Vaginitis:


leukorrhea, vaginal pruritus, vaginal odor, vaginal discomfort, vaginal pain or burning

Drugs & Therapeutics for Vaginitis

Drugs for Vaginitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 166)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Desogestrel Approved Phase 4 54024-22-5 40973
2
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-28-2 5757 53477783
3
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
4
Etonogestrel Approved, Investigational Phase 4 54048-10-1 40976 6917715
5
Acetaminophen Approved Phase 4 103-90-2 1983
6
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
7
Metronidazole Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 443-48-1 4173
8
Clindamycin Approved, Vet_approved Phase 4,Phase 3,Early Phase 1 18323-44-9 29029
9
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 22916-47-8 4189
10
Nystatin Approved, Vet_approved Phase 4,Phase 3 1400-61-9 11953884
11
Fluconazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 86386-73-4 3365
12
Neomycin Approved, Vet_approved Phase 4,Phase 3 1404-04-2 8378
13
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
14
Clotrimazole Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 23593-75-1 2812
15
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 53477736 447043
16
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
17
Tinidazole Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 19387-91-8 5479
18 Dequalinium Approved Phase 4,Phase 3 6707-58-0
19
Terconazole Approved Phase 4,Phase 3,Early Phase 1 67915-31-5 441383
20
Ephedrine Approved Phase 4,Phase 2,Phase 3 299-42-3 9294
21
Pseudoephedrine Approved Phase 4,Phase 2,Phase 3 90-82-4 7028
22
Norethindrone Approved Phase 4 68-22-4 6230
23 Contraceptive Agents Phase 4,Phase 3,Phase 2,Phase 1
24 Contraceptives, Oral Phase 4,Phase 3
25 Estradiol 17 beta-cypionate Phase 4,Phase 3,Phase 2,Phase 1
26 Estradiol 3-benzoate Phase 4,Phase 3,Phase 2,Phase 1
27 Estradiol valerate Phase 4,Phase 3,Phase 2,Phase 1 979-32-8
28 Estrogens Phase 4,Phase 3,Phase 2,Phase 1
29 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
30 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
31 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
32 Polyestradiol phosphate Phase 4,Phase 3,Phase 2,Phase 1
33 Progestins Phase 4,Phase 2
34 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Early Phase 1
35 Antibiotics, Antitubercular Phase 4
36 Antidotes Phase 4
37 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
38 Antioxidants Phase 4
39 Antiparasitic Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
40 Antiprotozoal Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
41 Antiviral Agents Phase 4
42 Expectorants Phase 4
43 N-monoacetylcystine Phase 4
44 Protective Agents Phase 4,Phase 2
45 Respiratory System Agents Phase 4,Phase 2,Phase 3
46 Clindamycin palmitate Phase 4,Phase 3,Early Phase 1
47 Clindamycin phosphate Phase 4,Phase 3,Early Phase 1
48 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
49 Ionophores Phase 4,Phase 3
50 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 222)
id Name Status NCT ID Phase
1 Probiotics Capsule as Supplemental Therapy for Group B Streptococci Infection and Vaginitis During Pregnancy Unknown status NCT01779193 Phase 4
2 Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers Unknown status NCT01448291 Phase 4
3 Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis Unknown status NCT01841411 Phase 4
4 Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy Unknown status NCT01558388 Phase 4
5 Open Study of the Efficacy of the Local Treatment With Polygynax of Bacterial and/or Mycotic Vaginitis Completed NCT02444481 Phase 4
6 Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis Completed NCT02014428 Phase 4
7 DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women Completed NCT01874158 Phase 4
8 Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections Completed NCT01697826 Phase 4
9 Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients Completed NCT03032848 Phase 4
10 Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers Completed NCT01329588 Phase 4
11 Safety and Tolerability of Metronidazole Gel 1.3% Completed NCT02392026 Phase 4
12 Treatment of Bacterial Vaginosis Combined With Human Lactobacilli Completed NCT01245322 Phase 4
13 Treatment of Bacterial Vaginosis (BV) With Tinidazole Completed NCT00334633 Phase 4
14 Treatment of Bacterial Vaginosis Completed NCT00324818 Phase 4
15 Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis Completed NCT00556179 Phase 4
16 Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis Completed NCT00642980 Phase 4
17 Clindamycin to Reduce Preterm Birth in a Low Resource Setting Completed NCT01800825 Phase 4
18 Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis Completed NCT02248506 Phase 4
19 Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis Completed NCT02242695 Phase 4
20 Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Completed NCT02180828 Phase 4
21 Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis Completed NCT02180100 Phase 4
22 Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina Completed NCT00194324 Phase 4
23 Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study Completed NCT00464542 Phase 4
24 Vaginal and Urinary Microbiome Trial Recruiting NCT02869165 Phase 4
25 Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections Recruiting NCT02860845 Phase 4
26 Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis Recruiting NCT02042287 Phase 4
27 The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis Recruiting NCT03080740 Phase 4
28 Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity Recruiting NCT02445989 Phase 4
29 Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity Recruiting NCT02432404 Phase 4
30 The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis Not yet recruiting NCT02905890 Phase 4
31 Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis Not yet recruiting NCT03099408 Phase 4
32 Colposeptine for the Treatment of Bacterial Vaginosis Terminated NCT01153958 Phase 4
33 Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis Unknown status NCT01420510 Phase 2, Phase 3
34 Safety and Efficacy Study of Gynevac Lactobacillus Vaccine in the Treatment of Bacterial Vaginosis Unknown status NCT02173184 Phase 3
35 A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial Vaginosis Unknown status NCT01089348 Phase 2, Phase 3
36 Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections Unknown status NCT02186145 Phase 3
37 Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis Unknown status NCT00889356 Phase 3
38 Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery Unknown status NCT00491270 Phase 3
39 Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion And Preterm Delivery In Pregnant Women With Previous Preterm Delivery Unknown status NCT01152528 Phase 3
40 The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients Unknown status NCT00536848 Phase 2, Phase 3
41 Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community Unknown status NCT00124878 Phase 3
42 Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis Completed NCT00137371 Phase 3
43 Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis Completed NCT02515656 Phase 3
44 A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ Completed NCT01867164 Phase 3
45 A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis Completed NCT02195986 Phase 3
46 A Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%) to Estrace® Cream (0.01%) in Postmenopausal Females With Atrophic Vaginitis Completed NCT02995694 Phase 3
47 Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial Completed NCT00464971 Phase 3
48 Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms Completed NCT00108849 Phase 3
49 Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis Completed NCT00431132 Phase 3
50 Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis Completed NCT02365389 Phase 2, Phase 3

Search NIH Clinical Center for Vaginitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: vaginitis

Genetic Tests for Vaginitis

Anatomical Context for Vaginitis

MalaCards organs/tissues related to Vaginitis:

39
Testes, Uterus, Colon, Cervix, Placenta, Neutrophil, Breast

Publications for Vaginitis

Articles related to Vaginitis:

(show top 50) (show all 2527)
id Title Authors Year
1
Vaginal vault prolapse in a patient with Mayer-Rokitansky-KA1ster-Hauser syndrome: a video case presentation. ( 28405713 )
2017
2
Vaginal Hysterectomy for Treatment of Cervical Ectopic Pregnancy. ( 27926641 )
2017
3
Resolution of Rectal Prolapse by Vaginal Reconstruction. ( 27898453 )
2017
4
Assessing the Experience of Vaginal Dilator Use and Potential Barriers to Ongoing Use among a Focus Group of Women with Mayer-Rokitansky-KA1ster-Hauser Syndrome. ( 28216131 )
2017
5
Topical tenofovir protects against vaginal SHIV infection in macaques co-infected with chlamydia trachomatis and trichomonas vaginalis. ( 28060011 )
2017
6
Effectiveness of intrauterine treatment with cephapirin in dairy cows with purulent vaginal discharge. ( 28043367 )
2017
7
Spinal extradural angiolipoma manifested after normal vaginal delivery. ( 26928853 )
2016
8
The "RESEAU MATER": An efficient infection control for endometritis, but not for urinary tract infection after vaginal delivery. ( 27592614 )
2016
9
Radical Hysterectomy and Total Abdominal Vaginectomy for Primary Vaginal Cancer. ( 26825828 )
2016
10
Co-infection with Bovine Herpesvirus 4 and Histophilus somni Significantly Extends the Service Period in Dairy Cattle with Purulent Vaginal Discharge. ( 26690881 )
2016
11
Heterogeneous polymer composite nanoparticles loaded in situ gel for controlled release intra-vaginal therapy of genital herpes. ( 27351137 )
2016
12
Deep infiltrating endometriosis: Should rectal and vaginal opacification be systematically used in MR imaging? ( 27216959 )
2016
13
Primary Vaginal Adenosarcoma With Sarcomatous Overgrowth Arising in Recurrent Endometriosis: Feasibility of Laparoscopic Treatment and Review of the Literature. ( 28034793 )
2016
14
Recto-vaginal septum cystadenocarcinoma: a case report and review of the literature. ( 27142415 )
2016
15
Variables associated with vaginal discharge after ultrasound-guided percutaneous microwave ablation for adenomyosis. ( 27087631 )
2016
16
Longitudinal Vaginal Septum Resection Using the Ligasure Device. ( 27321900 )
2016
17
A Phase II Clinical Trial Evaluating the Preventive Effectiveness of Lactobacillus Vaginal Suppositories in Patients with Recurrent Cystitis. ( 27549677 )
2016
18
Plastic neo-vaginal construction in Mayer-Rokitansky-KA1ster-Hauser syndrome: an expert opinion paper on the decision-making treatment process. ( 26904393 )
2016
19
Definitive treatment of primary vaginal cancer with radiotherapy: multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG 12-09). ( 26768782 )
2016
20
Vaginal-sparing ventral buccal mucosal graft urethroplasty for female urethral stricture: A novel modification of surgical technique. ( 27437540 )
2016
21
Chronic Uterine Inversion Presenting as a Painless Vaginal Mass at 6 Months Post Partum: A Case Report. ( 27437313 )
2016
22
Comparison of the Effects of Myrtus Communis L, Berberis Vulgaris and Metronidazole Vaginal Gel alone for the Treatment of Bacterial Vaginosis. ( 27134945 )
2016
23
Low-Grade Appendiceal Mucinous Neoplasm Involving the Endometrium and Presenting with Mucinous Vaginal Discharge. ( 27843660 )
2016
24
Postpartum Vaginal Stenosis Due to Chemical Vaginitis. ( 27437311 )
2016
25
Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis. ( 27103314 )
2016
26
The effect of luteal-phase support with vaginal progesterone on pregnancy rates in gonadotropin and clomiphene citrate/intra-uterine insemination cycles in unexplained infertility: A prospective randomised study. ( 27146108 )
2016
27
Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding. ( 27575538 )
2016
28
Efficacy and tolerability of combination cisplatin and ifosfamide chemotherapy with vaginal cuff brachytherapy in the first line treatment of uterine carcinosarcoma. ( 27172745 )
2016
29
Pregnancy With a Successful Vaginal Delivery Following Augmentation Enterocystoplasty for Ketamine Cystitis: A Case Report. ( 28043107 )
2016
30
Lateral-based Anterior Vaginal Wall Flap in the Treatment of Female Urethral Stricture: Efficacy and Safety. ( 27692474 )
2016
31
The feeling of discomfort during vaginal examinations, history of abuse and sexual abuse and post-traumatic stress disorder in women. ( 27603931 )
2016
32
Usefulness of anorectal and endovaginal 3D ultrasound in the evaluation of sphincter and pubovisceral muscle defects using a new scoring system in women with fecal incontinence after vaginal delivery. ( 28035460 )
2016
33
Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities. ( 26810061 )
2016
34
Utility of Laboratory Diagnosis for Confirmation of the Syndromic Case Management in Married Indian Women with Vaginal Discharge. ( 27833516 )
2016
35
Predictive value of the composition of the vaginal microbiota in bacterial vaginosis, a dynamic study to identify recurrence-related flora. ( 27253522 )
2016
36
Vaginal cancer possibly caused by pessary and immunocompromised condition: Multiple risk factors may influence vaginal cancer development. ( 26914159 )
2016
37
Draft Genome Sequence of Criibacterium bergeronii gen. nov., sp. nov., Strain CCRI-22567T, Isolated from a Vaginal Sample from a Woman with Bacterial Vaginosis. ( 27587833 )
2016
38
Necrotizing Myositis: A Severe Tension-Free Vaginal Tape-Obturator Surgical Site Infection. ( 27106190 )
2016
39
Diversity of Vaginal Lactic Acid Bacterial Microbiota in 15 Algerian Pregnant Women with and without Bacterial Vaginosis by using Culture Independent Method. ( 27790434 )
2016
40
Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral Treatment. ( 27191006 )
2016
41
Brachytherapy improves survival in primary vaginal cancer. ( 27036631 )
2016
42
Vaginal Inflammation: Association between Leukocyte Concentration and Levels of Immune Mediators. ( 26773532 )
2016
43
NORMAL VAGINAL BACTERIAL FLORA OF GIANT PANDAS (AILUROPODA MELANOLEUCA) AND THE ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF THE ISOLATES. ( 27010307 )
2016
44
Partial Cervical Agenesis and Complete Vaginal Atresia. ( 26620386 )
2016
45
Progresses in vaginal microflora physiology and implications for bacterial vaginosis and candidiasis. ( 27215488 )
2016
46
Do female patients with nonpathological vaginal discharge need the same evaluation as for Dhat syndrome in males? ( 26985107 )
2016
47
Vaginal Amebiasis Mimicking Cervical Cancer. ( 27746453 )
2016
48
Comparison between the efficacy of metronidazole vaginal gel and Berberis vulgaris (Berberis vulgaris) combined with metronidazole gel alone in the treatment of bacterial vaginosis. ( 27757195 )
2016
49
Menstrual, Sexual, and Obstetrical Outcomes after Vaginal Replacement for Vaginal Atresia Associated with Anorectal Malformation. ( 27846665 )
2016
50
How to diagnose and treat aerobic and desquamative inflammatory vaginitis. ( 27272705 )
2016

Variations for Vaginitis

Expression for Vaginitis

Search GEO for disease gene expression data for Vaginitis.

Pathways for Vaginitis

GO Terms for Vaginitis

Sources for Vaginitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....